MetaCap

Entrada Therapeutics (TRDA) News

NASDAQ: TRDAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.35-0.29 (-6.25%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TRDA news summary

We found 8 recent headlines mentioning Entrada Therapeutics (TRDA): 2 in the past week and 4 in the past 30 days, most often from GlobeNewswire, Nasdaq. TRDA is making an outsized move today, down 6.25% at $4.35, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Entrada Advised By DMC To Introduce Cohort 3 In Phase 1/2 For Duchenne Muscular Dystrophy", was published by Nasdaq on Nov 18, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Entrada Therapeutics headlines

Stocks mentioned alongside TRDA

Compare TRDA